期刊文献+

系统性红斑狼疮骨髓间质干细胞的初步研究 被引量:7

Study on Bone Marrow Mesenchymal Stem Cells in Systemic Lupus Erythematosus
原文传递
导出
摘要 目的探讨系统性红斑狼疮(SLE)患者骨髓间质干细胞(MSCs)生物学功能、细胞因子的表达异常与否。方法采用密度梯度离心和贴壁筛选法对10例SLE患者和11例正常人骨髓MSCs进行分离培养,流式细胞仪鉴定MSCs表面标志物及分析MSCs细胞周期和细胞凋亡,观察MSCs形态学改变,MTT法检测MSCs的生长情况,RT-PCR检测MSCs细胞因子mRNA水平表达。结果SLE骨髓MSCs传代率(30%)低于正常(100%)(P<0.01),SLE患者骨髓MSCs生长较正常活跃,凋亡率(2.36%)低于正常(6.79%),两组MSCs均表达CD29、CD44、CD105,均不表达CD14、CD34、CD45,SLE患者骨髓MSCsIL-7mRNA表达低于正常。结论SLE骨髓MSCs生物学特性及细胞因子表达存在异常。 Objective To explore the biological characters and cytokine expression of bone marrow mesenchymal stem cells (MSCs) from patients with systemic lupus erythematosus (SLE). Methods MSCs were isolated from bone marrow of both 10 SLE patients and 11 normal humans by density centrifugation and adhesive culture in vitro. The surface markers, cell cycle and cell apoptosis were detected by flow cytometry (FCM). The morphological change of MSCs was observed in primary and passage cultures. The proliferation of cells was determined by MTT colorimetric assay. The mRNA expression of cytokine secreted from MSCs was analysed with RT-PCR. Results The ex vivo passage rates of MSCs were 30% in SLE patients and 100% in normal controls, respectively (P〈0.01). MSCs from SLE grew faster than normal controls. The apoptotic percentage of MSCs was 2.36% in SLE and 6.79% in normal controls. Both groups express CD29, CD44 and CD105, but no express CD14, CD34 and CD45. IL-7 mRNA level of MSCs in SLE was less than the normal controls. Conclusion MSCs of SLE patients present the abnormalities in both biological characters and cytokine expression.
出处 《中华风湿病学杂志》 CAS CSCD 2005年第10期586-589,共4页 Chinese Journal of Rheumatology
基金 江苏省135重点人才培养基金资助项目(RC2002003) 南京市卫生局重点项目(ZKG9905)
  • 相关文献

参考文献9

  • 1Ikehara S. Autoimmune diseases as stem cell disorders: normal stem cell transplant for their treatment. Int J Mol Med, 1998, 1:5-16. 被引量:1
  • 2孙凌云.自身免疫病——造血干细胞病[J].中华风湿病学杂志,2000,4(1):5-6. 被引量:20
  • 3Papadaki HA, Boumpas DT, Gibson FM, et al. Increased apoptosis of bone marrow CD34+ cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus. Br J Haematol, 2001, 115: 167-174. 被引量:1
  • 4Frank MH, Sayegh MH. Immunomodulatory functions of mesenchymal stem cells. Lancet, 2004, 363:1411-1412. 被引量:1
  • 5Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1997, 40: 1725. 被引量:1
  • 6Bomkerdier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients: the committee on progress studies in SLE. Arthritis Rheum, 1992, 35: 630-640. 被引量:1
  • 7Ikehara S. New strategies for allogeneic BMT. Bone Marrow Transplant, 2003, 32: S73-75. 被引量:1
  • 8Beyth S, Borovsky Z, Mevorach D, et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T cell unresponsiveness. Blood, 2005, 105: 2214-2219. 被引量:1
  • 9Glennie S, Soeiro I, Dyson PJ, et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells.Blood, 2005, 105: 2821-2827. 被引量:1

二级参考文献2

共引文献19

同被引文献80

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部